Meningioma
Showing 1 - 25 of 662
Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)
Not yet recruiting
- Meningioma
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 21, 2023
Meningioma Trial in Heidelberg (Explorative biomarker study)
Not yet recruiting
- Meningioma
- Explorative biomarker study
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Oct 23, 2023
Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)
Recruiting
- Meningioma
- +2 more
- Biological biomarker assessment
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023
Meningioma Trial in San Francisco (drug, procedure, other)
Not yet recruiting
- Meningioma
- Hyperpolarized carbon C 13 pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 23, 2023
Meningioma Trial in Phoenix (Abemaciclib, Placebo)
Not yet recruiting
- Meningioma
- Abemaciclib
- Placebo
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Jul 4, 2023
Meningioma Trial (Endovascular embolization)
Recruiting
- Meningioma
- Endovascular embolization
-
Trondheim, NorwaySt Olavs Hospital
Oct 10, 2022
Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without
Recruiting
- Meningioma
- Radiation Toxicity
- Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
- +3 more
-
Caen, France
- +1 more
Sep 13, 2023
Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Meningioma
- Meningioma, Adult
- Avelumab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 27, 2022
Role of the Tumor Microenvironment in Aggressive Meningiomas
Not yet recruiting
- Meningioma
- Surgical waste and Data collect
- (no location specified)
Apr 7, 2023
Intracranial Meningioma Trial in Taoyuan (Radiation)
Not yet recruiting
- Intracranial Meningioma
- Radiation
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Apr 14, 2023
Cavernous Sinus Meningioma, Proton-therapy, Photon Radiotherapy Trial in France (Proton-therapy, Photon radiotherapy)
Not yet recruiting
- Cavernous Sinus Meningioma
- +3 more
- Proton-therapy
- Photon radiotherapy
-
Caen, France
- +6 more
May 31, 2023
Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)
Recruiting
- Grade 1 Meningioma
- +4 more
- Gallium Ga 68-DOTATATE
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Oncological Care for Patients With Meningioma
Recruiting
- Atypical Meningioma
- +5 more
-
Montpellier, FranceUh Montpellier
Apr 13, 2022
Tranexamic Acid, Intraoperative Blood Loss, Meningioma Trial in Beijing (Continous infusion, Single infusion, Placebo)
Recruiting
- Tranexamic Acid
- +2 more
- Continous infusion
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Aug 24, 2022
Meningioma Trial in Miami (Cabozantinib)
Recruiting
- Meningioma
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc
Jun 17, 2022
Meningioma Patient-derived Organoids
Recruiting
- Meningioma
-
Hong Kong, Hong KongDepartment of Surgery, The Chinese University of Hong Kong
Mar 8, 2022
Meningioma Trial (Radiotherapy 68 Gy(RBE), Radiotherapy 72 Gy(RBE), Radiotherapy 60 Gy(RBE))
Not yet recruiting
- Meningioma
- Radiotherapy 68 Gy(RBE)
- +2 more
- (no location specified)
Aug 2, 2022
Meningioma Trial in New York (Ga-68- DOTATATE, Ga-68-DOTATOC)
Recruiting
- Meningioma
- Ga-68- DOTATATE
- Ga-68-DOTATOC
-
New York, New YorkWeill Cornell Medical College of Cornell University
Apr 10, 2022
Petro-trigeminal Line and Petrous Apex Cephaloceles
Recruiting
- Petrous Apex Meningioma
-
Strasbourg, FranceService de Radiologie 1 - CHU de Strasbourg - France
Nov 25, 2022
Meningioma Trial in Heidelberg (Carbon Ion Radiotherapy)
Active, not recruiting
- Meningioma
- Carbon Ion Radiotherapy
-
Heidelberg, GermanyUniversity Hopsital Heidelberg
Aug 23, 2022
Seizures, Meningioma Trial in Beijing (Tranexamic acid, 0.9% saline)
Active, not recruiting
- Seizures
- Meningioma
- Tranexamic acid
- 0.9% saline
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Jan 1, 2023
Predictive Factors of Visual Recovery After Paraoptic Tumors
Recruiting
- Tuberculum Sellae Meningioma
-
Paris, FranceFondation Ophtalmologique Adolphe de Rothschild
Sep 19, 2022
68-Ga DOTATATE PET/MRI in Diagnosis and Management of
Recruiting
- CNS Tumors
- +6 more
- Ga68-DOTATATE-PET/MRI
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022